SUMMARY The inhibitory effect of Bacteroides fragilis on the in vitro killing of Escherichia coli by polymorphonuclear leucocytes was studied with two pairs of E coli and B fragilis isolated from human wound infections. Both B fragilis strains behaved similarly: they inhibited the killing of one E coli strain, while the killing of the other E coli strain was not affected. The different behaviour of the two E coli strains depended on their need for fresh serum in the killing by the polymorphonuclear leucocytes. The inhibitory effect of the B fragilis strains could be completely accounted for by their effect on complement.
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The early bacteriologists who had to convince a sceptical world of the role of bacteria in disease laid great emphasis on isolating pure cultures from infected lesions. This need for pure cultures is implicit in the famous postulates of Koch. Although it was soon realised that bacterial species seemed to assist each other in producing infections-for example, Meleney's synergistic gangrene and foot rot in sheep-most attention was paid to identifying pure cultures as causative micro-organisms. Recently, the increasing importance of commensal infections, such as wound infections and infections after gastrointestinal surgery, has stimulated interest in bacteria which seem to play a synergistic role with each other. An understanding of their interplay is important not only for elucidating the pa;hogenesis of the infection but also for optimal diagnosis and treatment. The well known synergy between members of the genus bacteroides and enterobacteria has been variously explained. One possible explanation is the inhibitory effect that these anaerobic bacteria have on the in vitro phagocytosis of enterobacteria, as described by several authors. ' Anaerobic bacteria from the frozen stock culture were cultured on a BM agar plate supplemented with 5% sheep blood, haemin, and menadione. A pure culture from a single colony was grown in liquid BM medium with haemin and menadione at 37°C in the anaerobic chamber. After 18 h the cultures contained 2 -5 x 108 colony forming units per millilitre, as determined by viable counts. Unless the whole culture was used, the bacteria were washed once in PBS and resuspended to the original volume.
In some experiments bacteria were killed by incubating them for 1 h at 70°C or by shaking the bacteria for 30 min with 0-5% formalin. In both cases the bacteria were washed afterwards and resuspended in PBS to the original volume.
In some experiments Staphylococcus aureus (Oxford strain) NCTC 6571 was used; it was cultured and treated as described for E coli.
POLYMORPHONUCLEAR LEUCOCYTES
Polymorphs were separated from heparinised blood of healthy donors by dextran sedimentation. They were washed three times with Hank's balanced salt solution (HBSS) (Gibco Laboratory, Grand Island, NY) with 0-1% gelatin, buffered with bicarbonate at pH 7*3 (gel-HBSS), and suspended to a concentration of 107 cells/ml.
SERUM
Pooled human serum from healthy human donors was used in all experiments as the source of opsonins. In experiments with preopsonised E coli 108 bacteria were incubated with 50% serum in 1 ml PBS in a shaking waterbath at 110 rpm and 37°C. After 30 min the bacteria were washed and resuspended in PBS to the same concentration. In experiments in which preabsorbed serum was used, equal volumes of serum and bacterial suspension, or for controls PBS, were mixed. The mixture was incubated with gentle shaking at 37°C or at 4°C. After 30 min the serum was filter sterilised and used in the killing experiments at a final concentration of 10% (vol/vol). Antibody titres against the four E coli and B fragilis strains in normal and absorbed sera were measured with indirect immunofluorescence according to standard procedures, using FITC labelled rabbit antihuman immunoglobulins (Bio-Merieux, Charbonieres les Bains, France). Complement depletion in these sera was measured by determining 50% haemolytic units (CH5,) as described by Mayer.'3 KILLING EXPERIMENT Reaction mixtures were prepared in sterile polypropylene tubes (12 x 75 mm, Rofa Mavi, Beverwijk, The Netherlands), each containing 0-5 ml of the polymorph suspension (107 cells/ml), 0-1 ml serum, 0-1 ml E coli, 0 1 ml B fragilis and 0-2 ml gel-HBSS, unless otherwise stated. The reaction mixture was incubated in a Julabo Paramix shaking apparatus (Rofa Mavi) at 400 rpm in a CO2 incubator with a humidified atmosphere of 95% air and 5% CO2 at 37°C. After 0, 30, 60, and 90 min 0-1 ml of the reaction mixture was suspended in 9 9 ml of distilled water to lyse the polymorphs. Viable counts of E coli were carried out by plating serial dilutions on nutrient agar plates, which were incubated aerobically. Viable B fragilis were counted by plating serial dilutions on BM agar supplemented with haemin and menadione and 50,ug/ml nalidixic acid, which inhibited the growth of E coli. The plates were incubated for 48 h in the anaerobic chamber.
Statistical analysis was performed with Student' s t test.
Results
E coli EB1 and E coli EB4 were both killed by polymorphs when normal serum was present. B fragilis BEl was not killed, whereas about 70% of B fragilis BE4 was killed after 90 min. None of these strains was affected by serum alone, and the anaerobes survived well the 90 min aerobic incubation in the killing experiments. Both B fragilis BEl and BE4 significantly inhibited the killing of E coli EB1 ( Fig. 1 ; p < 0-01 at 30, 60, and 90 min), but not of E coli EB4 (Fig. 2) . 100
The Significance of difference from control: *not significant, tp < 0-1, tp < 0-001, §P < 0-01. Significance of difference from control: *p < 0-001, tp < 0-01, tp < 0.01.
paratively little complement, killing was also inhibited, but not completely. When serum was treated with B fragilis at 4°C instead of 37°C, no inhibition of the killing of EB 1 was found (Fig. 3) . Therefore, competition for cross reacting antibodies could not have been responsible for the inhibition. This was confirmed when antibodies were determined with immunofluorescence: the antibody titre against each of the four strains was not affected by absorption with any of the other three, and only slightly reduced by absorption with the strain itself (data not shown). Complement was essential for the killing of E coli EB 1 but not of EB4, which was killed almost 100- as well in the absence of serum as in its presence (Table 4) .
Thus of the two clinically isolated pairs of E coli and B fragilis only one pair showed synergy in the Table 4 Killing by polymorphonuclear leucocytes ofE coli EBI and E coli EB4: effect ofserum sense that the anaerobe inhibited the killing of the aerobe by polymorphs. The occurrence of this inhibition depended on the properties of the aerobenamely, on its requirement of complement for killing.
Discussion
In this study the inhibitory effect of two strains of B fragilis on the killing of their aerobic partners was studied in vitro. Our results agree with the conclusions drawn when the pathogenic properties of these paired strains were tested in mice.9 B fragilis BEl and BE4 both have a substantial effect on the clearance of a low dose of subcutaneously injected E coli EB1, and abscesses are the result. This phenomenon was not found with an equal dose of E coli EB4, which shows that the synergy is dependent on the E coli strain. Likewise, in vitro inhibition of killing is found for E coli EB1, but not for EB4. This dependence of the inhibition of the killing on the E coli strain used has also been described earlier by Wade et al.5 These authors do not state, however, whether E coli 2882, the strain for which killing was not inhibited by B fragilis in their experiments, was killed by polymorphs in the absence of serum, a phenomenon which explained the lack of inhibition of the killing of our strain E coli EB4. The failure of Reznikov et al'°to show any effect of B fragilis on the clearance of E coli in mice could also be due to the E coli strain tested.
The results in this study are in agreement with the hypothesis that inhibition of the killing is the result of competition for opsonins and confirm the findings of other authors.' 34 5 The dependence of the inhibitory power of B fragilis on low redox potential, which was noted by some authors, ' inhibit serum dependent killing of E coli and that this in vitro phenomenon is achieved not only by anaerobes. Data are not given in the above mentioned reports, however, to indicate whether the inhibiting species themselves are killed by polymorphs. This might be important, since wasting of large amounts of complement on bacteria which are not killed subsequently would be more disadvantageous to the host than the use of complement for the destruction of a second infecting species.
It is not clear what part of the bacteroides cell is responsible for the inhibitory effect. The possession of a capsule is considered to be of great importance for virulence,'4-5 and encapsulation is reported to impair the phagocytosis of bacteroides cells,'61I The role of the capsule in the inhibition of the killing of other species is controversial, since experiments with purified capsular material give conflicting results.518 Moreover, the occurrence of capsules among different bacteroides species, within one species, and even within one strain is variable. '9 From the report by Conolly et al'8 and from our own observations encapsulation does not seem to be related to inhibitory effects on the killing. Nevertheless, if the killing inhibiting effect is non-specific, as indicated by Wade et als and by this paper, the question remains unanswered why B fragilis is encountered much more often in mixed abdominal infections than would be expected from its prevalence in the gut.
